FDA approves IceCure’s ProSense system for breast cancer
The cryoablation treatment is indicated for women aged 70 and above with early-stage, low-risk breast tumours.
Cancer
Northwestern University announces new RNA detection method for cancer
Novocure obtains approval for Optune Lua device in Japan to treat NSCLC
People-focused cancer care demands policy support
Revolutionising breast cancer diagnosis: Seno Medical gains Vizient contract
Aethlon Medical enrols first patient in trial of Hemopurifier device for cancer
KFSHRC partners with University of Birmingham for bladder cancer diagnosis
Pangea Laboratory and Unilabs to introduce Bladder CARE Assay in Switzerland
